论文部分内容阅读
本文28例经活检组织学证实及骨髓涂片示细胞增生低下的非选择性原发性再障贫血患者,采用同化激素治疗。其中1例于住院2天后死亡。3例使用羟甲雄酮(Oxymetholone),24例用metenolone(Primobolan)治疗。口服给药。剂量除1例200mg/天外,其余病例均为75～150mg/天。5例合并使用皮质激素,其中2例是用同化激素无效后而改用皮质激素长期治疗。支持疗法包括使用抗菌素和输给各种血细胞成份。疗效标准:治疗3个月后如无明显出血倾向,不需输血而血红蛋白上升3克以上,
In this paper, 28 cases of non-selective primary aplastic anemia confirmed by biopsy histology and bone marrow smear showed hyperplasia, the use of anabolic hormone therapy. One of them died within 2 days of hospitalization. Three patients received Oxymetholone and 24 patients received metenolone (Primobolan). Oral administration. In addition to a dose of 200mg / day, the remaining cases were 75 ~ 150mg / day. 5 cases were combined with corticosteroids, of which 2 cases were treated with corticosteroids long-term treatment after the use of anabolic hormones invalid. Supportive therapies include the use of antibiotics and the loss of various blood cell components. Efficacy standards: 3 months after treatment if there is no obvious bleeding tendency, no blood transfusion and hemoglobin increased by 3 grams or more,